Bluebird Bio Raises $30 Million Series C To Accelerate Pipeline Development
Gene therapy biotech hopes to move lead program for childhood cerebral adrenoleukodystrophy into a registrational trial later this year.
Gene therapy biotech hopes to move lead program for childhood cerebral adrenoleukodystrophy into a registrational trial later this year.